Respiratory Syncytial Virus (RSV) cases in Australia have reached 83,000 this year, surpassing both Covid-19 and influenza totals, according to data from the Immunisation Foundation of Australia (IFA) and the Australian Medical Association (AMA). Health officials warn that the country is on track to record over 127,000 cases by the end of winter.
Comparing Respiratory Virus Trends: RSV vs. Covid-19 and Flu
Current health data reveals a shift in the dominant respiratory threats facing Australians this season. RSV is now the primary driver of respiratory illness, outstripping other common winter viruses in total case numbers.
According to the IFA and AMA, the current breakdown of recorded cases is as follows:
- RSV: 83,000 cases
- Covid-19: 51,000 cases
- Influenza: Nearly 50,000 cases
The scale of the outbreak is significant. Approximately 890 confirmed cases of RSV have been reported daily since the start of winter. While RSV often presents as a cold-like disease, it remains the leading cause of hospitalization for the youngest and oldest Australians due to its tendency to cause serious respiratory issues in those with weaker immune systems.
Did you know? The infant immunisation program has already reduced infant hospital admissions in autumn and early winter by 70% since 2024.
RSV Vaccination Gaps in Older Populations
Despite the availability of a free vaccine, a significant portion of the vulnerable elderly population remains unprotected. IFA founder Catherine Hughes reports that more than one million older Australians have not yet taken the free RSV vaccine.
The rollout for those aged 75 and over began in May 2026. However, Ms. Hughes noted a critical timing gap, stating the vaccine was “unfortunately not available in April and early May when many older Australians receive their flu shot.” This misalignment has left a “massive gap” in coverage that requires urgent attention.
AMA president Dr. Danielle McMullen emphasizes that the vaccine is a simple tool to prevent hospitalizations. She urges eligible citizens to speak with healthcare professionals immediately, noting that “winter is far from over.”
Success Rates of Infant Immunisation Programs
While older adults face a coverage gap, the program for infants has seen substantial success. Since the nationwide program launched last year, more than 360,000 Australian babies have received protection against severe RSV.
Ms. Hughes describes the program as a “resounding success,” citing evidence that thousands of families have avoided the trauma of having infants admitted to intensive care or requiring oxygen support. The vaccine has been free for pregnant mothers since February 2025, providing early protection for newborns.
Pro Tip: Eligible Australians can access free vaccines at participating local pharmacies, community health centres, and GPs. Check your eligibility based on age or pregnancy status before booking.
Frequently Asked Questions
What is RSV and how does it spread?
RSV is a common respiratory infection that spreads similarly to the cold or flu. While it feels like a cold for many, it can cause severe respiratory distress in infants and the elderly.
Who is eligible for the free RSV vaccine in Australia?
The vaccine is free for pregnant mothers (since February 2025) and all individuals aged 75 and over (since May 2026).
Where can I get the RSV vaccine?
You can receive the vaccine at participating GPs, community health centres, and local pharmacies.
Are you or a family member eligible for the free RSV vaccine? Share your experience with the rollout or ask a question in the comments below. For more health updates, subscribe to our newsletter.
Related reading